首页> 外文期刊>Current Nanoscience >A Method to Prepare Solid Lipid Nanoparticles with Improved Entrapment Efficiency of Hydrophilic Drugs
【24h】

A Method to Prepare Solid Lipid Nanoparticles with Improved Entrapment Efficiency of Hydrophilic Drugs

机译:一种提高亲水药物包封率的固体脂质纳米粒的制备方法

获取原文
获取原文并翻译 | 示例
       

摘要

Introduction: Premise of the present study was to suitably select or modify the constitution of the lipid matrix to achieve significantly high entrapment of hydrophilic drugs within solid lipid nanoparticles (SLNs). Methods and Materials: Isoniazid was selected as a representative hydrophilic drug with a high solubility of 230 mg/ml and a log P of -0.402 at 25℃ (determined as per OECD TG 105 and 107 respectively). Three lipids/fatty acids (Glyceryl monostearate, Compritol 888 ATO and stearic acid) were evaluated out of which Compritol 888 ATO and stearic acid showed favorable interactions (FTIR and DSC studies) with isoniazid. The two lipids were used alone or in combination for preparing SLNs. Formulation of SLNs by microemulsification, method involved pouring the hot micro-emulsion into cold water under constant stirring, which may result in expulsion of the hydrophilic drug from the lipid matrix; hence, partitioning of isoniazid from the hot lipid melts into cold water was also determined. Results and Discussion: Results indicate that combining stearic acid with Compritol 888 ATO in certain ratio (1:4) led to significant entrapment efficiency (EE) of 84.0±1.1%. The formulations were subjected to morphological, physiochemical and in vitro drug release studies. Developed SLNs were found to be stable for 1 year at 4℃. Conclusion: The study demonstrates the benefit of excipient screening techniques in improving entrapment efficiency of a hydrophilic drug.
机译:简介:本研究的前提是适当选择或修改脂质基质的组成,以使亲水性药物在固体脂质纳米颗粒(SLNs)中的包裹率显着提高。方法和材料:选择异烟肼作为代表性的亲水性药物,其高溶解度为230 mg / ml,在25℃时的log P为-0.402(分别根据OECD TG 105和107测定)。评估了三种脂质/脂肪酸(单硬脂酸甘油酯,Compritol 888 ATO和硬脂酸),其中Compritol 888 ATO和硬脂酸与异烟肼显示出良好的相互作用(FTIR和DSC研究)。两种脂质单独或组合用于制备SLN。通过微乳化制备SLN,该方法涉及在恒定搅拌下将热微乳倒入冷水中,这可能导致亲水性药物从脂质基质中排出。因此,还确定了异烟肼从热脂质熔体分配到冷水中的情况。结果与讨论:结果表明,硬脂酸与Compritol 888 ATO以一定比例(1:4)结合使用时,显着的包封率(EE)为84.0±1.1%。对制剂进行形态学,理化和体外药物释放研究。发现已开发的SLN在4℃稳定1年。结论:该研究证明了赋形剂筛选技术在提高亲水性药物的包封效率方面的益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号